Evidence map›Paper›PMID 27535081›Full record

SynthesisSchizophrenia bulletin2017

Improving Prognostic Accuracy in Subjects at Clinical High Risk for Psychosis: Systematic Review of Predictive Models and Meta-analytical Sequential Testing Simulation.

André Schmidt, Marco Cappucciati, Joaquim Radua, Grazia Rutigliano, Matteo Rocchetti, Liliana Dell'Osso, Pierluigi Politi, Stefan Borgwardt, Thomas Reilly, Lucia Valmaggia and 2 more

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Schizophrenia bulletin, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Observational
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

André SchmidtDepartment of Psychosis Studies PO63, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Marco CappucciatiDepartment of Psychosis Studies PO63, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Joaquim RaduaDepartment of Psychosis Studies PO63, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Grazia RutiglianoDepartment of Psychosis Studies PO63, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Matteo RocchettiDepartment of Psychosis Studies PO63, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Liliana Dell'OssoDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Pierluigi PolitiDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
Stefan BorgwardtDepartment of Psychosis Studies PO63, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Thomas ReillyDepartment of Psychosis Studies PO63, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Lucia ValmaggiaDepartment of Psychosis Studies PO63, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Philip McGuireDepartment of Psychosis Studies PO63, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Paolo Fusar-PoliDepartment of Psychosis Studies PO63, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Discriminating subjects at clinical high risk (CHR) for psychosis who will develop psychosis from those who will not is a prerequisite for preventive treatments. However, it is not yet possible to make any personalized prediction of psychosis onset relying only on the initial clinical baseline assessment. Here, we first present a systematic review of prognostic accuracy parameters of predictive modeling studies using clinical, biological, neurocognitive, environmental, and combinations of predictors. In a second step, we performed statistical simulations to test different probabilistic sequential 3-stage testing strategies aimed at improving prognostic accuracy on top of the clinical baseline assessment. The systematic review revealed that the best environmental predictive model yielded a modest positive predictive value (PPV) (63%). Conversely, the best predictive models in other domains (clinical, biological, neurocognitive, and combined models) yielded PPVs of above 82%. Using only data from validated models, 3-stage simulations showed that the highest PPV was achieved by sequentially using a combined (clinical + electroencephalography), then structural magnetic resonance imaging and then a blood markers model. Specifically, PPV was estimated to be 98% (number needed to treat, NNT = 2) for an individual with 3 positive sequential tests, 71%-82% (NNT = 3) with 2 positive tests, 12%-21% (NNT = 11-18) with 1 positive test, and 1% (NNT = 219) for an individual with no positive tests. This work suggests that sequentially testing CHR subjects with predictive models across multiple domains may substantially improve psychosis prediction following the initial CHR assessment. Multistage sequential testing may allow individual risk stratification of CHR individuals and optimize the prediction of psychosis.

Indexed as

Models, TheoreticalPrognosisHumansPsychotic Disordersclinical high-riskearly interventionspredictionprognostic accuracypsychosistreatment prognosis

Identifiers

PMID27535081
PMCPMC5605272

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.